Goldline Pharmaceutical Limited IPO

Goldline Pharmaceutical Limited IPO

SME BSE SME 100% Book Built Offer
Upcoming

Price Band

₹41 - ₹43

Total Issue

₹12 Cr

Bid Dates

12 May - 14 May

Subscription

-

Est. GMP

₹0 (0.00%)

Website RHP Check Allotment

Valuation

Market Cap

₹41.28 Cr

P/E Ratio

10.49x

P/B Ratio

3.47x

Goldline Pharma IPO Dates

Open
Close
Allotment
Refunds
Credit
Listing

Conflicting IPOs

IPOs with overlapping timeline

Business Overview

Goldline Pharmaceutical Limited, incorporated in 2004 and headquartered in Nagpur, Maharashtra, is engaged in the marketing and distribution of pharmaceutical products under the proprietary brand 'Goldline. It operates an asset-light, third-party manufacturing model, outsourcing production to 15 contract manufacturers while directing all internal resources toward brand development, marketing, and distribution. Its product portfolio is organized into 5 distinct therapeutic segments: Goldline Pharma (42 multi-specialty products), Goldline Cardinal (54 cardio-diabetic products), Goldline Aayushman (18 gynaecology and paediatric products), Goldline InLife (22 injectable and critical care products), and Goldline Wellness (10 oncology supportive care products). Products are distributed exclusively through a network of 8 distributors to wholesalers and retailers. The company is promoted by Mr. Amol Mujumdar and Mr. Swapan Khandelwal, who bring 25 and 30 years of experience respectively in pharmaceutical marketing.

Goldline Pharma IPO Lot Size

Lot Information for Goldline Pharma IPO
Category Lots Shares Amount
Ind (Min) 2 6,000 ₹2,58,000
Ind (Max) 2 6,000 ₹2,58,000
S-HNI (Min) 3 9,000 ₹3,87,000
S-HNI (Max) 7 21,000 ₹9,03,000
B-HNI (Min) 8 24,000 ₹10,32,000
Allocate Funds
Market Maker
₹1.38 L
Employee
₹0.00
Shareholder
₹0.00

Goldline Pharma IPO Size

Total ₹11.61 Cr
Fresh Issue
₹12 Cr (0.27 Cr Shares)
Offer For Sale
₹0 (0.00 Shares)

Objects of the Issue

Repayment of all or a portion of certain outstanding borrowings availed by the Company

₹8.35 Cr

General corporate purposes & issue expenses

₹3.26 Cr

Total

₹11.61 Cr

Goldline Pharma IPO IPO Details Live GMP

GMP ₹0
Est. Price ₹43
Est. Gain 0.00%

Goldline Pharma IPO Peer Comparison

(Rs. in crores)

Goldline Pharma IPO Peer Comparison Table
Particulars Goldline Pharma Mono Pharmacare Chandra Bhagat Pharma
Revenue 28.06 168.34 86.72
PAT 2.83 3.09 0.86
EPS (₹) 4.10 1.75 1.14
NAV (₹) 12.38 17.66 39.72
RONW 27.37% 9.90% 2.86%
EBITDA 20.78% 6.17% 4.69%
PAT Mrgn 10.09% 3.74% 0.99%
PE Ratio 10.49 7.57 28.94
Debt to Equity 1.50 1.72 0.70

All information pertains to FY 2024-25. PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of April 29, 2026 for Peers

Goldline Pharma IPO IPO Financial Performance

(Rs. in crores)

Financial Performance Metrics for Goldline Pharma IPO
Particulars Dec-25 Mar-25 Mar-24 Mar-23
Revenue 21.41 28.06 23.57 19.85
PAT 2.22 2.83 1.80 0.26
Net Worth 12.36 10.35 7.86 5.89
Borrowings 9.47 11.03 11.13 10.83
Assets 27.40 26.28 22.93 19.39
NAV (₹) 15.29 12.38 8.78 6.35
EPS (₹) 3.22 4.10 3.01 0.43

Key Performance Indicators (KPIs)

EBITDA

20.78%

PAT

10.09%

ROE

35.83%

ROCE

38.45%

Debt to Equity

1.50

Promoter Holding

Promoter

79.70%

Public

20.30%

Amol Laxmikant Mujumdar 39.85%
Swapan Premprakash Khandelwal 39.85%

Management

Amol Laxmikant Mujumdar MD
Swapan Premprakash Khandelwal WTD
Dipti Sharad Bhusari CFO

Registrar & Lead Managers

Lead Managers (1)

Company Details

Name: Goldline Pharmaceutical Limited

Address: 103, F-1, Leela Apartment, Shilpa HSG Society, Near Saptagiri Nagar, Shanidham, Narendra Nagar, Nagpur – 440 015, Maharashtra, India

Number: +91 712 278 6666

Email: info@goldlinepharma.in

Website: https://www.goldlinepharma.in

Frequently Asked Questions (FAQs)

What is Goldline Pharma IPO?
Goldline Pharma IPO is a SME IPO having an issue size of ₹12 Crs. Goldline Pharma IPO is priced at ₹41 - ₹43 per share. The issue opens on 12 May 26 and closes on 14 May 26.
When will Goldline Pharma IPO open?
Goldline Pharma IPO opens on 12 May 26 and closes on 14 May 26.
What is the GMP of Goldline Pharma IPO?
The estimated Grey Market Premium of Goldline Pharma IPO is ₹0 per share (0.00%).
What is the lot size of Goldline Pharma IPO?
The minimum lot size of Goldline Pharma IPO is 3000 shares & the minimum application amount is Rs. 129000.
When is the allotment of Goldline Pharma IPO?
The allotment date of Goldline Pharma IPO is 15 May 26.
What is the listing date of Goldline Pharma IPO?
The listing date of Goldline Pharma IPO is 19 May 26.
What is the subscription of Goldline Pharma IPO?
Goldline Pharma IPO is subscribed -.
What is the price band of Goldline Pharma IPO?
Goldline Pharma IPO is priced at ₹41 - ₹43 per share.
How to check allotment status of Goldline Pharma IPO?
Click the allotment link on Goldline Pharma IPO page of IPO360.
How to apply Goldline Pharma IPO in Zerodha?
  1. Go to Kite App → Tap on Bids → Tap on IPO
  2. Select the IPO → Tap on apply → Enter UPI ID
  3. Enter Qty and Price
  4. Submit the application
  5. Approve the UPI Mandate on your UPI app
How to apply Goldline Pharma IPO in Groww?
  1. Go to Groww App → Stocks Section → Select IPO option
  2. Select the IPO you want to apply
  3. Enter your bid details and price
  4. Enter UPI ID & submit
  5. Approve the UPI Mandate on your UPI app
How to apply Goldline Pharma IPO using ASBA?
  1. Log in to your bank's net banking portal.
  2. Navigate to the 'IPO' or 'ASBA' section.
  3. Select Goldline Pharma IPO from the list of available IPOs.
  4. Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
  5. Submit the application.
  6. Money will remain blocked till the refund date